JSA advised the Anthea group and the existing shareholders of Anthea Aromatics Private Limited (“Anthea”) including ICICI Ventures, Mr. Paul Vincent Menacherry and Mr. Mathew Vincent Menacherry (promoters of Anthea group) in relation to an investment of up to INR 1000 Crores by India Resurgence Fund (“IndiaRF”), a leading India focussed investment platform which is a 50:50 joint venture of the Piramal group and Bain Capital. Following the transaction, IndiaRF has become a controlling shareholder of Anthea.
Anthea which was established in 1992 and has grown into a leading aroma specialty chemicals group in India. The company operates five manufacturing facilities across Maharashtra and Karnataka including through two joint venture companies: DRT Anthea Aroma Chemicals Private Limited (joint venture between Anthea and Les Dérivés Résiniques et Terpéniques SAS) and Catasynth Specialty Chemicals Private Limited, with a combined capacity of 10,590 tons per annum.
Anthea has a strong R&D setup and a successful track record of development and production across a broad range of specialty chemicals, catering to growing end-use applications across flavors and fragrances, home and personal care, pharmaceutical and agrochemical industries. Each of the products are critical input in end-use applications without easily available substitutes.
Our Transaction Team Comprised Lead Partner Tirthankar Datta, Partner – Avantika Govil, Senior Associate – Harshil Shubham, Associate – Ciol Kumar.
Our Employment Law Team Comprised Partner – Maneesh Upadhyay, Associate – Yash Shah and Abhay Almal.
Avantika focuses on mergers & acquisitions and private equity investments. She has extensive experience in advising clients in corporate and business restructuring, strategic collaborations and cross-border investments across sectors.